Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant Enterococcus faecium

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 11, 2012, Pages 6051-6053

  Humphries, Romney M ^a   Kelesidis, Theodoros ^a   Tewhey, Ryan ^b   Rose, Warren E ^c   Schork, Nicholas ^b,d   Nizet, Victor ^e   Sakoulas, George ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CYTOCHROME C; DAPTOMYCIN; MANNOSE; PHOSPHOENOLPYRUVATE; PHOSPHOTRANSFERASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL SURFACE; CELL SURVIVAL; CELL WALL; ENTEROCOCCUS FAECIUM; GENE MUTATION; GENE PRODUCT; GENE SEQUENCE; GENOTYPE; MEMBRANE FLUIDITY; MINIMUM INHIBITORY CONCENTRATION; OPEN READING FRAME; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADAPTATION, PHYSIOLOGICAL; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CELL MEMBRANE; CLONE CELLS; DAPTOMYCIN; ENTEROCOCCUS FAECIUM; GENOTYPE; MEMBRANE PROTEINS; MICROBIAL SENSITIVITY TESTS; OPEN READING FRAMES; PHENOTYPE; PHOSPHOTRANSFERASES; POLYMORPHISM, SINGLE NUCLEOTIDE; STATIC ELECTRICITY; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS); VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84868018494     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01318-12     Document Type: Article

References (22)

1. Adams DW, Errington J. 2009. Bacterial cell division: assembly, maintenance and disassembly of the Z ring. Nat. Rev. Microbiol. 7:642-653.
2. Arias CA, et al. 2011. Genetic basis for in vivo daptomyin resistance in enterococci. N. Engl. J. Med. 365:892-900.
3. Aziz RK, et al. 2008. The RAST server: rapid annotations using subsystems technology. BMC Genomics 9:75. doi:10.1186/1471-2164-9-75.
4. Bayer AS, et al. 2000. In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity. Infect. Immun. 68:3548-3553.
5. Cintas LM, et al. 2000. Enterococcus faecium L50 produces enterocins L50A and L50B, the sec-dependent enterocin P, and a novel bacteriocin secreted without and N-terminal extension termed enterocin Q. J. Bacteriol. 182:6806-6814.
6. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, eighth edition. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Diep DB, Skaugen M, Salehian Z, Holo H, Nes IF. 2007. Common mechanisms of target cell recognition and immunity for class II bacteriocins. Proc. Natl. Acad. Sci. U. S. A. 104:2384-2389.
8. Fisher S, et al. 2011. A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries. Genome Biol. 12:R1. doi:10.1186/gb-2011-12-1-r1.
9. Hernandez D, Francois P, Farinelli L, Osteras M, Schrenzel J. 2008. De novo bacterial genome sequencing: millions of very short reads assembled on a desktop computer. Genome Res. 18:802-809.
10. Jones T, et al. 2008. Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob. Agents Chemother. 52:269-278.
11. Kelesidis T, Chow ALP, Humphries R, Uslan DZ, Pegues D. 2012. Case-control study comparing de novo and daptomycin-exposed daptomycin- nonsusceptible Enterococcus infections. Antimicrob. Agents Chemother. 56:2150-2152.
12. Kelesidis T, Humphries R, Uslan DZ, Pegues D. 2012. Daptomycin non-susceptible enterococcus infections among patients with no prior daptomycin exposure. Emerg. Infect. Dis. 18:674-676.
13. Kelesidis T, Humphries R, Uslan DZ, Pegues DA. 2011. Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin. Infect. Dis. 52:228-234.
14. Kent WJ. 2002. BLAT - the BLAST-like alignment tool. Genome Res. 12:656-664.
15. Kjos M, Nes IF, Diep DB. 2009. Class II one-peptide bacteriocins target a phylogenetically defined subgroup of mannose phosphotransferase systems on sensitive cells. Microbiology 155:2949-2961.
16. Li H, Durbin R. 2009. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754-1760.
17. Li H, et al. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25:2078-2079.
18. Lunter G, Goodson M. 2011. Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. Genome Res. 21:936-939.
19. Palmer KL, Daniel A, Hardy C, Silverman J, Gilmore MS. 2011. Genetic basis for daptomycin resistance in enterococci. Antimicrob. Agents Chemother. 55:3345-3356.
20. Rose WE, Knier RM, Hutson PR. 2010. Pharmacodynamic effect of clinical vancomycin exposures on cell wall thickness in heterogeneous vancomycin-intermediate Staphylococcus aureus. J. Antimicrob. Chemother. 65:2149-2154.
21. Sakoulas G, et al. 2012. Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium. Antimicrob. Agents Chemother. 56:838-844.
22. Yang SJ, et al. 2010. Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms. Antimicrob. Agents Chemother. 54:3079-3085.